The p-tau217 blood test has improved the diagnostic accuracy of Alzheimer’s to 88% when combined with PET scans, lumbar ...

Telix Pharmaceuticals and St Vincent's Hospital announced the first patients have been dosed with TLX597-Tx in the OPTIMAL-e trial, targeting earlier stage prostate cancer treatment in Melbourne and ...

Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...

Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use ...

A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International ...

Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring ...

Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the ...

New Mexico Cancer Center will become the first healthcare provider in the state to offer estrogen receptor (ER)-targeted PET ...

A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.